AT
Aldeyra The
🇩🇪XFRA.137GermanyHealthcare
€1.20EURup +0.02 (+1.69%)ClosedEnd of day1:27 AM
Price€1.20+0.02 (+1.69%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US01438T1060
- CUSIP
- Not reported
Company
- Employees
- 6
- Headquarters
- Lexington, United States
- Website
- https://www.aldeyra.com
- CEO
- Dr. Todd C. Brady M.D., Ph.D.
Market
- Shares outstanding
- 60.3M
- Market cap
- €72.39M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- €71.19M
- EPS LTM
- -$0.38
- P/E LTM
- -5.57
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$23.05M+54.46%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$22.04M+46.28%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.